Get started
Author

Zohra Alimirzoyeva

Observed names: Alimirzoeva, Zohra, Alimirzoyeva, Zohra, Z Alimirzoyeva, Z Kh Alimirzoeva, Z. Alimirzoeva, Z. Alimirzoyeva, Zohra Alimirzoeva
ORCID: 0009-0000-1630-9641
Observed ORCID: 0009-0000-1630-9641
OpenAlex ID: A5038287631
β-Thalassemia intermedia: a comprehensive overview and novel approaches
2018 · Chingiz Asadov, Zohra Alimirzoeva, et al. · International Journal of Hematology · 82
Update on Prevention of Hemoglobinopathies in Azerbaijan
2024 · Tahira Mammadova, Chingiz Asadov, et al. · Hemoglobin · 8
Association of CYP3A5*3, CYP3A4*18 & CYP2B6*6 polymorphisms with imatinib treatment outcome in Azerbaijani chronic myeloid leukaemia patients
2023 · Chingiz Asadov, Nigar Karimova, et al. · International Journal of Microbiology Research · 8
Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia
2023 · Aypara Hasanova, Chingiz Asadov, et al. · Pathology & Oncology Research · 6
PDF
Clinical Application of Recombinant Erythropoietin in Beta-thalassaemia Intermedia.
2016 · Ch Asadov, Z Alimirzoyeva, et al. · PubMed · 6
Digital Medicine and Artificial Intelligence in Chronic Myeloid Leukemia: Current Applications, Challenges, and Future Directions
2026 · Chingiz Asadov, Aytan Shirinova, et al. · Cureus · 3
PDF
Unique Gender-Related Characteristics and Differences of Chronic Myeloid Leukemia Patients in Azerbaijan: A Retrospective Cohort Study
2025 · Aytan Shirinova, Chingiz Asadov, et al. · Cureus · 2
PDF
Role of genetic factors in imatinib resistance of chronic myeloid leukemia: P53, RB1, ASS1 gene deletions, and chromosome 8 hyperdiploidy
2025 · Aypara Hasanova, Chingiz Asadov, et al. · Pathology - Research and Practice · 1
Rationale of ferroportin inhibition for beta-thalassemia management
2022 · Chingiz Asadov, Gunay Aliyeva, et al. · Drugs of the Future · 1
Sp-065 Modern Principles of Management of Thalassemia Intermedia
2014 · Zohra Alimirzoeva, Mehbara Hasanova, et al. · Leukemia Research · 1
Efficiency of recombinant erythropoietin administration in hemoglobinopathy H.
2014 · M Hasanova, Ch Asadov, et al. · PubMed · 1
[The serum erythropoietin under intermediate B-thalassemia].
2012 · Ch D Asadov, M B Gasanova, et al. · PubMed · 1
A rare cytogenetic constellation in chronic myeloid leukemia: concurrent Philadelphia chromosome, del(5q), and monosomy 7 at diagnosis
2026 · Aypara Hasanova, Chingiz Asadov, et al. · Egyptian Journal of Medical Human Genetics
PDF
Digital Technologies and Artificial Intelligence in the Diagnosis, Monitoring, and Prevention of Thalassemia: Current Status, Limitations, and Future Perspectives
2026 · Chingiz Asadov, Aytan Shirinova, et al. · Medical Research Archives
PDF
16-Year Epidemiologic Study of Chronic Myeloid Leukemia in Azerbaijan: Clinical and Molecular Insights
2026 · Aytan Shirinova, Chingiz Asadov, et al. · Journal of Clinical Medicine of Kazakhstan
Impact of Beta-Thalassemia Trait on Clinical Outcomes and Treatment Response in Chronic Myeloid Leukemia
2026 · Aytan Shirinova, Chingiz Asadov, et al. · Cureus
PDF
A cohort study of molecular response to Imatinib in patients with chronic-phase chronic myeloid leukemia in Azerbaijan
2025 · Aypara Hasanova, Chingiz Asadov, et al. · Discover Medicine
PDF
Sequential Development of Chronic Lymphocytic Leukemia Eleven Years after Chronic Myeloid Leukemia in a Caucasian Male: A Case Report
2025 · Shirinova, Aytan, Alimirzoyeva, Zohra, et al. · HAL
Analysis of Response to First-line Therapy With Imatinib in Azerbaijani Cml Patients
2025 · Aypara Hasanova, Chingiz Asadov, et al. · Hematology Transfusion and Cell Therapy
The current situation of multiple myeloma in Azerbaijan
2019 · C. Asadov, A. Shirinova, et al. · Leukemia Research
Pb1920 Bcr‐abl Gene Abl Kinase Domain Mutations in Imatinib Resistant Chronic Myeloid Leukemia Patients From Azerbaijan
2019 · C. Asadov, A. Hasanova, et al. · HemaSphere
Works count: 22
Citation count: 120
H-index: 5
I10-index: 1
Year
Topic
Type